Revenue and Growth
Total revenue increased 17% to $6.1 million in Q1 2025 compared to $5.2 million in Q1 2024, driven by the acquisition of the Rhode Island radiation therapy operations and launch of operations in Puebla, Mexico.
Expansion and Strategic Initiatives
The acquisition of a 60% majority interest in three Rhode Island radiation therapy treatment centers and the launch of operations in Puebla, Mexico, represent significant growth steps. Additionally, the upcoming opening of a new center in Guadalajara, Mexico, is expected to further drive growth.
International Business Development
The company is expanding its international presence with the only Gamma Knife centers in Peru and Ecuador, and a new center in Puebla, Mexico. A new center in Guadalajara, Mexico is expected to open by the end of the year.